Our results showed a significant increase in cortical Aβ aggregates in MetS-induced and resistin-treated APP/PSN1 animals compared to controls, while ApN treatment caused a significant reduction in cortical Aβ deposition (Figures 5A, B). Here, NT5C3A is linked to metabolic syndrome.